Keyphrases
High-risk Neuroblastoma
100%
Induction Therapy
100%
Confidence Interval
66%
Early Toxicity
66%
Event-free Survival
50%
Randomized Controlled Trial
50%
Health-related Quality of Life
50%
Risk of Bias
50%
Treatment-related Mortality
50%
Treatment Group
50%
Complete Response
50%
Hematotoxicity
50%
Renal Toxicity
50%
Progression-free Survival
33%
Risk Classification
33%
Overall Survival
33%
Hazard Ratio
33%
Body Surface Area
33%
Ototoxicity
33%
Toxicity Grades
33%
Febrile Neutropenia
33%
Risk Ratio
33%
Review Authors
33%
Glomerular Filtration Rate
33%
Short Intervals
33%
Neurocognitive Complications
33%
Septicemia
33%
Endocrine Complications
33%
Free Care
33%
Neuroblastoma
16%
Tumor
16%
Adverse Events
16%
Chemotherapy
16%
Selection Criteria
16%
Metastasis
16%
Adverse Outcomes
16%
PubMed
16%
Preoperative Chemotherapy
16%
Very Young children
16%
Embase
16%
MEDLINE
16%
Cochrane
16%
Classification System
16%
Publication Bias
16%
Early Treatment
16%
High Dose
16%
Gastrointestinal Toxicity
16%
Trial Registries
16%
Patient Characteristics
16%
Treatment Duration
16%
Late Toxicity
16%
High-risk Population
16%
Neurotoxicity
16%
Induction Chemotherapy
16%
Fungal Infection
16%
Issue 11
16%
Ovid
16%
Conference Proceedings
16%
Publication Year
16%
Risk Response
16%
Short-term Treatment
16%
Malignant Disease
16%
Second Malignancy
16%
Mortality Risk
16%
Treatment Alternatives
16%
Low Power
16%
Search Methods
16%
Dose Intensity
16%
Dose Increase
16%
Patient-assessed
16%
Abdominal Mass
16%
Overall Survival Progression-free Survival
16%
International Neuroblastoma Risk Group
16%
Speech Difficulties
16%
Language of Publication
16%
Learning Difficulties
16%
Treatment-based Classification
16%
Medicine and Dentistry
Ganglioneuroblastoma
100%
Event Free Survival
37%
Overall Survival
37%
Progression Free Survival
37%
Randomized Controlled Trial
37%
Quality of Life
37%
Nephrotoxicity
37%
High Risk Population
25%
Hazard Ratio
25%
Arm
25%
Ototoxicity
25%
Febrile Neutropenia
25%
Body Surface
25%
Glomerular Filtration Rate
25%
Septicemia
25%
Neoplasm
12%
Disease
12%
Adverse Event
12%
Treatment Response
12%
Second Cancer
12%
Metastatic Carcinoma
12%
Adverse Outcome
12%
Systematic Review
12%
Preoperative Chemotherapy
12%
Toddlers
12%
Learning Disorder
12%
Drug Megadose
12%
Patient Characteristics
12%
Speech Production
12%
Mycosis
12%
Gastrointestinal Toxicity
12%
Induction Chemotherapy
12%
Single Drug Dose
12%
Abdominal Mass
12%
Drug Dose Increase
12%
Chemotherapy
12%
Pharmacology, Toxicology and Pharmaceutical Science
Neuroblastoma
100%
Event Free Survival
37%
Overall Survival
37%
Chemotherapy
37%
Randomized Controlled Trial
37%
Progression Free Survival
37%
Nephrotoxicity
37%
Ototoxicity
25%
Febrile Neutropenia
25%
Septicemia
25%
Neoplasm
12%
Disease
12%
Mycosis
12%
Adverse Event
12%
Gastrointestinal Toxicity
12%
Adverse Outcome
12%
Second Cancer
12%
Learning Disorder
12%
Abdominal Mass
12%